PUBLICATIONS LIST JJ Carrero (Sept 2014)
1. Peer-reviewed articles.
2003
1.
E López-Huertas, L Baró, JJ Carrero, J Fonollá, J Jiménez, J Boza. “n-3 fatty acids-enriched foods.
Cardiovascular disease as a target”. Nutrafoods (2003). 2(1) 13-19.
2.
E López-Huertas, L Baró, JJ Carrero, J Fonollá, J Jiménez, J Boza. “n-3 fatty acids: health effects
and opportunities to increase intake” AGROfood industry hi-tech (2003). May/June 18-21.
3.
JJ Carrero, M González-Santiago, J Fonollá, L Baró, Jiménez J, Boza J. and E López-Huertas.
”Health effects due to folic acid supplementation. Food fortification strategies to achieve adequate
folate status” Nutrafoods (2004). 3(1) 5-13
4.
JJ. Carrero, L Baró, J Fonollá, M González-Santiago, A Martínez-Férez, R Castillo, J Jiménez, JJ
Boza and E López-Huertas. “Cardiovascular effects of milk enriched with omega-3 polyunsaturated
fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia”.
Nutrition. (2004) 20(6): 521-527
5.
JJ Carrero, E Martín-Bautista, L Baró, J Fonollá, J Jiménez, J Boza and E López-Huertas.
“Cardiovascular effects of omega-3-fatty acids and alternatives to increase their intake”. Nutr Hosp
(2005) 20(1): 56-62
6.
JJ Carrero, E López-Huertas, LM Salmerón, L Baró, E Ros. “Daily supplementation with (n-3)
PUFAs, oleic acid, folic acid and vitamins B-6 and E increases pain-free walking distance and
improves risk factors in men with peripheral vascular disease” J Nutr. (2005) 135(6):1393-9.
7.
MP González-Santiago, E Martín-Bautista, JJ Carrero, J Fonollá, L Baró, M V Bartolomé, P GilLoyzaga, E López-Huertas. “Administration of hydroxytyrosol, a phenolic antioxidant present in olive
oil, improves blood lipids, antioxidant status and reduces the development of atherosclerosis in
hyperlipemic rabbits” Atherosclerosis, 2006 Sep;188(1):35-42.
8.
JJ Carrero and RF Grimble. “Does nutrition have a role in peripheral vascular disease?” Br J Nutr.
2006 Feb;95(2):217-29.
9.
Lopez-Huertas E, Teucher B, Boza JJ, Martínez-Férez A, Baró L, Carrero JJ, González-Santiago
M, Fonolla J, Fairweather-Tait S. “Absorption of calcium from milks enriched with fructooligosaccharides, caseinophosphopeptides, tricalcium phosphate and milk solids”. Am J Clin Nutr.
2006 Feb;83(2):310-6.
2004
2005
2006
10. JJ Carrero, VE Ramos, LM Salmeron, E Lopez-Huertas y E Ros. “Estudio de las repercusiones
clínicas y analíticas de una intervención nutricional en pacientes no hospitalizados con claudicación
intermitente. Estudio aleatorio controlado”. Angiologia 2006, 58(1): 19-30.
11. Axelsson J, Carrero JJ, Avesani CM, Heimbürger O, Lindholm B, Stenvinkel P. Adipokine signaling
in the peritoneal dialysis patient. In: Peritoneal Dyalisis, a clinical update. Ed. Ronco, C. Contrib
Nephrol. 2006; 150:166-73.
12. Carrero JJ, Axelsson J, Avesani CM, Heimbürger O, Lindholm B, Stenvinkel P. Being an inflamed
peritoneal dialysis patient, a Dante´s journey. In: Perinoteal Dyalisis, a clinical update. Ed. Ronco, C.
Contrib Nephrol. 2006; 150:144-51
13. Suliman ME, Johnson RJ, Garcia-Lopez E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O,
Bárány P, Axelsson J, Lindholm B and Stenvinkel P. “J-shaped mortality relationship for uric acid in
chronic kidney disease” Am J Kidney Dis. 2006 Nov;48(5):761-771.
14. Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P. “Inflammation and
muscle wasting in chronic kidney disease; Partners in crime” Kidney Int Suppl. 2006 Dec;(104):S8S13.
15. Carrero JJ, Lopez-Huertas E, Salmeron LM, Ramos VE, Baro L, Ros E. “Simvastatin
supplementation with w-3 polyunsaturated fatty acids and vitamins improves claudication distance in
a randomized PILOT study in patients with peripheral vascular disease” Nutrition Research 26
(2006) 637– 643.
16. Axelsson J, Moller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimburger O, Barany P, Alvestrand A,
Lindholm B, Moestrup SK, Stenvinkel P. “Changes in fat mass correlate with changes in soluble
sCD163, a marker of mature macrophages, in patients with chronic kidney disease”. Am J Kidney
Dis. 2006 Dec;48(6):916-25.
2007
17. Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, Lopez-Huertas E. “Intake of fish oil, oleic acid,
folic acid, and vitamins b-6 and e for 1 year decreases plasma c-reactive protein and reduces
coronary heart disease risk factors in male patients in a cardiac rehabilitation program” J Nutr. 2007
Feb;137(2):384-90.
18. Axelsson J, Carrero JJ, Lindholm B, Heimburger O, Stenvinkel P. “Malnutrition in patients with Endstage renal disease – Anorexia, cachexia and catabolism.” Current Nutrition & Food Science. 2007;
3, 37-46.
19. Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimburger O, Barany P, Lindholm B,
Alvestrand A, Schalling M, Nordfors L, Stenvinkel P. “Circulating Levels of Visfatin/Pre–B-Cell
Colony–Enhancing Factor 1 in Relation to Genotype, GFR, Body Composition, and Survival in
Patients With CKD”. Am J Kidney Dis. 2007 Feb; 49(2):237-44.
20. Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Snaedal S, Bárány P, A Alvestrand,
Lindholm B, Heimbürger O and Stenvinkel P. “Comparison of nutritional and inflammatory markers
in dialysis patients with poor appetite”. Am J Clin Nutr. 2007 March; 85(3):695-701.
21. Garcia-Lopez E, Carrero JJ, Suliman ME, Lindholm B and Stenvinkel P. “Cardiovascular disease
risk factors in patients undergoing peritoneal dialysis”. Perit Dial Int 2007 27: S205–S209
22. Yilmaz MI, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Low-grade inflammation in chronic
kidney disease patients before the start of renal replacement therapy: sources and consequences.
Clin Nephrol 2007; 68(1):1-9
23. Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Axelsson J, Alvestrand A,
Stenvinkel P, Lindholm B, Suliman ME. Plasma pentraxin 3 in chronic kidney disease patients:
Associations with renal function, protein-energy wasting, cardiovascular disease and mortality.
cJASN. 2007 Sep;2(5):889-97
24. Grindt M, Stenvinkel P, Ulrich C, Axelsson J, Nordfors L, Barany P, Carrero JJ, Heine GH, Kaul H,
Köhler H. “Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic
hemodialysis patients”. Nephrol Dial Transplant. 2007 Dec;22(12):3586-92.
25. Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rhenmark S, Witt MR, Bárány P, Alvestrand A,
Heimbürger O, Lindholm B and Stenvinkel P. Clinical and biochemical implications of low thyroid
hormones (total and free forms) in euthyroid patients with chronic kidney disease. JIM 2007
Dec;262(6):690-701.
26. Carrero JJ, Heimbürger O, Lindholm B and Stenvinkel P. In reply to Molfino et al. Am J Clin Nutr
2007 86: 1551-1553
2008
27. Carrero JJ, Aguilera A, Stenvinkel P, Selgas R, Lindholm B. Appetite disorders in uremia. J Ren
Nutr 2008 Jan. 18(1): 107-113.
28. Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Vural A,
Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term treatment with sevelamer increases
serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4
patients. Clin J Am Soc Nephrol. 2008 Jan;3(1):61-8.
29. Yilmaz MI, Sonmez A, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Cakir E, Oguz Y,
Vural A, Yenicesu M, Lindholm B, Stenvinkel P and Axelsson J. ADMA levels correlate with
proteinuria, secondary amyloidosis, and endothelial dysfunction. J Am Soc Nephrol. 2008
Feb;19(2):388-95
30. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Acikel C,
Cakir E,
Yenicesu M, Lindholm B, Stenvinkel P and Axelsson J. “Serum visfatin concentration and
endothelial dysfunction in chronic kidney disease”. Nephrol Dial Transplant. 2008 Mar;23(3):959-65.
31. Carrero JJ, Stenvinkel P, Fellström B, Qureshi AR, Lamb K, Heimbürger O, Barany P,
Radhakrishnan K, Lindholm B, Soveri I, Nordfors L, Shiels PG. Telomere attrition is associated to
inflammation, low fetuin-A levels and high mortality in prevalent hemodialysis patients. J Intern Med.
2008 Mar;263(3):302-12.
32. Stenvinkel P, Carrero JJ, Axelsson J, Heimburger O, Lindholm B, Massy Z. Emerging biomarkers
for evaluating cardiovascular risk in the chronic kidney disease patient: How do new pieces fit into
the uremic puzzle? Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21.
33. Carrero JJ, Yilmaz MI, Lindholm B, Stenvinkel P. Cytokine dysregulation in chronic kidney disease.
How can we treat it? Blood Purif. 2008 Apr 18;26(3):291-299.
34. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A, Cakir E, Oguz Y,
Vural A, Yenicesu M, Stenvinkel P, Lindholm B and Axelsson J. Endothelial dysfunction in type-2
diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial
Transplant. 2008 May;23(5):1621-7.
35. Suliman ME, Qureshi AR, Carrero JJ, Barany P, Yilmaz, MI, Snaedal-Jonsdottir S, Alvestrand A,
Heimburger O, Lindholm B, Stenvinkel P. Plasma Pentraxin-3 in prevalent hemodialysis patients:
Associations with comorbidities and mortality. QJM. 2008 May;101(5):397-405.
36. Ruiz JR, Ortega FB, Warnberg J, Moreno LA, Carrero JJ, Gonzalez-Gross M, Marcos A, Gutierrez
A, Sjöström M. “Inflammatory proteins are associated with muscle strength in adolescents. The
AVENA study” Arch Pediatr Adolesc Med. 2008 May;162(5):462-8.
37. Carrero JJ, Shiels PG, Stenvinkel P. Telomere biology alterations as a mortality risk factor in
chronic kidney disease. Am J Kid Dis. 2008 May; 51(6):1076-77.
38. Madden J, Carrero JJ, Brunner A, Dastur N, Shearman CP, Calder PC, Grimble RF.
Polymorphisms in the CD 36 gene modulate the ability of fish oil supplements to lower fasting
plasma triacylglycerol and raise HDL cholesterol concentrations in healthy middle aged men.
Prostaglandins Leukot Essent Fatty Acids. 2008 Jun;78(6):327-35.
39. Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Heimburger
O, Barany P, Alvestrand A, Lindhollm B, Stenvinkel P. Novel links between pentraxin-3, endothelial
dysfunction and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol.
2008 Jul;3(4):976-85.
40. Carrero JJ, Chmielewski M, Heimbürger H, Axelsson J, Snaedal-Jonsdottir S, Suliman ME, Bárány
P, Lindholm B, Stenvinkel P and Qureshi AR. Muscle atrophy, protein-energy wasting, inflammation
and clinical outcome in pre- and hemodialysis patients. Clinical Nutrition 2008 Aug;27(4):557-64.
41. Valli A, Carrero JJ, Qureshi AR, Garibotto G, Barany P, Anderstam B, Stenvinkel P, Lindholm B,
Suliman ME. Elevated serum S-adenosylhomocysteine levels, but not the concentration of
homocysteine, is associated with cardiovascular disease in stage 5 chronic kidney disease patients.
Clin Chim Acta. 2008 Sep;395(1-2):106-10.
42. Chmielewski M, Carrero JJ, Lindholm B, Norfords L, Stenvinkel P. Lipid disorders in chronic kidney
disease - reverse epidemiology and therapeutic. J Nephrol. 2008 September-October;21:635-644.
43. Luttrop K, Stenvinkel P, Carrero JJ, Pecoits-Filho R, Lindholm B, Nordfors L. Understanding the
role of genetic polymorphisms in chronic kidney disease. Pediatr Nephrol. Pediatr Nephrol. 2008
Nov;23(11):1941-9.
44. Metry G, Stenvinkel P, Qureshi AR, Carrero JJ, Yilmaz MI, Bárány P, Snaedal S, Heimbürger O,
Lindholm B and Suliman ME. Fetuin-A is associated with mortality only in inflamed hemodialysis
patients. Eur J Clin Invest 2008 38 (11): 804-11.
45. Axelsson J, O’Byrne SM, Blaner WS, Carrero JJ, Bruchfeld A, Heimbürger O, Bárány P, Lindholm
B, and Stenvinkel P. Serum retinol-binding protein (RBP) concentration and its’ association with
components of the uremic metabolic syndrome in non-diabetic patients with chronic kidney disease
stage 5. Am J Nephrol. 2008 Nov 21;29(5):447-453.
46. Chmielewski M, Stenvinkel P, Luttropp K, Suliman ME, Qureshi AR, Carrero JJ, Barany P,
Heimburger O, Nordfors L, Lindholm B. LPL 1595 C/G and HL -480 C/T polymorphisms - impact on
lipid profile in incident dialysis patients. Blood Purif. 2008 Dec 2;26(6):555-560.
2009
47. Carrero JJ. Identification of patients with eating disorders: clinical and biochemical signs of appetite
loss in dialysis patients. J Ren Nutr. 2009 Jan;19(1):10-5.
48. Carrero JJ, Brodin L, Lindholm B, Stenvinkel P. Adiponectin in chronic kidney disease – Dr. Jekyll
and Mr. Hyde. Kidney Int. 2009 Jan;75(1):120-1.
49. Carrero JJ, Ortiz A, Qureshi AR, Martin-Ventura JL, Barany P, Heimburger O, Marron B, Metry G,
Snaedal-Jonsdottir, Lindholm B, Egido J, Stenvinkel P, Blanco-Colio JL. Additive effects of soluble
TWEAK and inflammation on mortality in hemodyalized patients. Clin J Am Soc Nephrol. 2009
Jan;4(1):110-8.
50. Avesani CM, Carrero JJ. Estimating total versus resting energy expenditure. Methodological
considerations. Clin Nutr. Clin Nutr. 2009 Feb;28(1):103.
51. Chmielewski M, Carrero JJ, Stenvinkel P, Lindholm B. Metabolic abnormalities in chronic kidney
disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the
risk. Curr Opin Lipidol. 2009 Feb;20(1):3-9.
52. Carrero JJ, Qureshi AR, Parini P, Arvid S, Lindholm B, Bárány P, Heimbürger O and Stenvinkel P.
Low serum testosterone increases mortality risk in male dialysis patients. J Am Soc Nephrol. 2009
Mar;20(3):613-620.
53. Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K, Kirkpantur A, Celik
T, Oguz Y, Vural A, Yenicesu M, Lindholm B and Stenvinkel P. The effect of renin angiotensin
system blockade on pentraxin 3 levels in diabetic patients with proteinuria. Clin J Am Soc Nephrol.
2009 Mar;4(3):535-41.
54. Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A, Oguz Y, Arslan I,
Vural A, Yenicesu M, Stenvinkel P, Lindholm B and Axelsson J. Normalization of endothelial
dysfunction following renal transplantation is accompanied by a reduction of circulating
visfatin/NAMPT. A novel marker of endothelial damage?. Clinical Transplantation 2009
Mar;23(2):241-8.
55. Bruchfeld A, Carrero JJ, Qureshi AR, Lindholm B, Barany P, Heimburger O, Hu M, Lin X,
Stenvinkel P, Miller E. Elevated serum macrophage migration inhibitory factor (MIF) concentrations
in Chronic Kidney Disease (CKD) are associated with markers of oxidative stress and endothelial
dysfunction. Mol Med. 2009 Mar-Apr;15(3-4):70-5.
56. Chmielewski M*, Carrero JJ*, Qureshi AR, Axelsson J, Heimbürger O, Berglund L, Bárány P,
Rutkowski B, Lindholm B and Stenvinkel P. Temporal discrepancies in the association between the
apoB/apoA-I ratio and mortality in incident dialysis patients. J Intern Med. 2009 Jun;265(6):708-16. *
Equally contributed.
57. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-
Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P. Comorbidity and acute clinical
events as determinants of CRP variation in hemodialysis patients and their association with
survival. Am J Kidney Dis. 2009 Jun;53(6):1024-33
58. Cordeiro AC, Carrero JJ, Abensur H, Lindholm B, Stenvinkel P. Systemic and Local Inflammation in
Peritoneal Dialysis: Mechanisms, Biomarkers and Effects on Outcome. Contrib Nephrol. 2009
Jun;163:132-139.
59. Cano NJM, Aparicio M, Brunori G, Carrero JJ, Cianciaruso B, Fiaccadori E, Lindholm B, Teplan V,
Fouque D, Guarnieri G. Parenteral nutrition in adult renal failure. ESPEN Guidelines. Clin Nutr. 2009
Aug;28(4):401-14.
60. Carrero JJ*, Hua X*, Stenvinkel P, Qureshi AR, Heimbürger O, Barany P, Lindholm B, Frostegard
J. IgM antibodies against phosphorylcholine-A and mortality in patients undergoing hemodialysis.
Nephrol Dial Transplant. 2009 Nov;24(11):3454-60. *Equally contributed
61. Guo QY, Carrero JJ, Bárány P, Qureshi AR, Eriksson M, Anderstam B, Chmielewski M, Heimbürger
O, Stenvinkel P, Lindholm, B, Axelsson J. Associations of sVEGFR-1 and 2 with nutrition,
cardiovascular disease and survival in prevalent hemodialysis patients. Nephrol Dial Transplant.
2009 Nov;24(11):3468-73.
62. Muntinghe FLH, Verduijn M, Zuurman MW, Grootendorst D, Carrero JJ, Qureshi AR, Luttropp K,
Nordfors L, Brandenburg V, Stenvinkel S, Boeschoten EW, Krediet RT, Navis, G, Dekker FW. Cchemokine receptor 5 deletion (CCR5Δ32) polymorphism protects against the increased mortality
rate seen in dialysis patients with chronic inflammation. J Am Soc Nephrol. 2009 Jul;20(7):1641-9.
63. Park SH, Carrero JJ, Lindholm B, Stenvinkel P. Adiponectin in chronic kidney disease has opposite
links to protein-energy wasting and to cardiovascular risk: two sides of the same coin. Clin Nephrol.
2009 Aug; 72:87-96.
64. Carrero JJ, Park SH, Axelsson J, Lindholm B, Stenvinkel P. Cytokines, atherogenesis and
hypercatabolism in chronic kidney disease: a dreadful triad. Semin Dial. 2009 Jul-Aug;22(4):381-6.
65. Yamamoto T, Carrero JJ, Lindholm B, Stenvinkel P Axelsson J. Leptin and uremic protein-energy
wasting. The axis of eating. Semin Dial. 2009 Jul-Aug;22(4):387-90.
66. Luttrop K, Lindholm B, Carrero JJ, Glorieux G, Vanholder R, Schalling M, Stenvinkel P, Nordfors L.
Genetics in chronic kidney disease – towards personalized medicine! Semin Dial. 2009 JulAug;22(4):417-22.
67. Yilmaz MI*, Carrero JJ*, Ortiz A, Martin-Ventura JL, Sonmez A, Saglam M, Yaman H, Yenicesu M,
Egido J, Blanco-Colio LM. Soluble TWEAK plasma levels as a novel biomarker of endothelial
function in subjects with chronic kidney disease. Clin J Am Soc Nephrol. 2009 Nov;4(11):1716-23.
*Equally contributed.
68. Raj DSC*, Carrero JJ*, Shah VO, Qureshi AR, Barany P, Moseley P, Heimburger O, Ferguson J
and Stenvinkel P. Soluble CD14 Levels, Interleukin-6 and Mortality Among Prevalent Hemodialysis
Patients. Am J Kidney Dis. 2009 Dec;54(6):1072-80. * Equally contributed.
69. Carrero JJ and Stenvinkel P. Nutrition: Can ghrelin improve appetite in uremic wasting? Nat Rev
Nephrol. 2009 Dec;5(12):672-673.
70. Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelson J, Heimburger O, Barany O, Lindholm
B, Suliman ME. Inflammation modifies the association of osteoprotegerin with mortality in chronic
kidney disease. J Nephrol. 2009 Nov-Dec;22(6):774-82.
71. Carrero JJ and Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic
kidney disease; a hypothesis proposal. Clin J Am Soc Nephrol 2009 Dec. 4: S49-S55.
2010
72. Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten T, Cakir E, Oguz Y,
Vural A, Yenicesu M, Axelsson J. Predictors of carotid artery intima-media thickness in chronic
kidney disease and kidney transplant patients without overt cardiovascular disease. Am J Nephrol
2010 31(3):214-221.
73. Carrero JJ, Cordeiro AC, Lindholm B, Stenvinkel P. The emerging pleiotropic role of adipokines on
the uremic phenotype. Curr Opin Nephrol Hypertens. 2010 Jan;19(1):37-42.
74. Cordeiro AC, Qureshi AR, Axelsson J, Barany P, Heimburger O, Stenvinkel P, Lindholm B, Carrero
JJ. Abdominal fat accumulation is linked to increased inflammation, protein energy wasting and
worse outcome in prevalent patients undergoing hemodialysis. Nephrol Dial Transplant. 2010
Feb;25(2):562-8.
75. Molanaei H, Carrero JJ, Heimbürger O, Nordfors L, Lindholm B, Stenvinkel P, Odar-Cederlöf I, and
Bertilsson L. The influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition
in patients with chronic kidney disease. Eur J Clin Pharmacol. 2010 Mar;66(3):269-73.
76. Carrero JJ, Witasp A, Qureshi AR, Suliman ME, Schalling M, Barany P, Heimburger O, Norfors L,
Lindholm B, Stenvinkel P, Axelsson J. Visfatin is increased in chronic kidney disease patients with
poor appetite and correlates negatively with fasting serum amino acids and triacylglycerol levels.
Nephrol Dial Transplant. 2010 Mar;25(3):901-6.
77. MI Yilmaz*, JJ Carrero*, JL Martín-Ventura, A Sonmez, M Saglam, H Yaman, M Yenicesu, J Egido,
LM Blanco-Colio. Combined therapy with Renin Angiotensin System and Calcium Channel Blockers
in Type-2 Diabetic Hypertensive Patients with Proteinuria: Effects on TWEAK, PTX3 and flow
mediated dilatation. Clin J Am Soc Nephrol. 2010 Jul;5(7):1174-81. *equally contributed
78. Korkeila M, Carrero JJ, Cederholm T and Stenvikel P. Ghrelin – en ny möjlighet att behandla dålig
aptit och undernäring vid kronisk katabol sjukdom. Läkartidningen. 2010 Jul;24-25(108): 1627-1628.
79. Anderwald C, Ankersmit HJ, Badaoui A, Beneduce L, Buko VU, Calo LA, Carrero JJ, Chang CY,
Chang KC, Chen YJ, Cnotliwy M, Costelli P, Crujeiras AB, Cuocolo A, Davis PA, de Boer OJ,
Ebenbichler CF, Erridge C, Fassina G, Felix SB, García-Gómez MC, Guerrero-Romero F, Haider
DG, Heinemann A, Herda LR, Hoogeveen EK, Hörl WH, Iglseder B, Huang KC, Kaser S, Kastrati A,
Kuzniatsova N, Latella G, Lichtenauer M, Lin YK, Lip GY, Lu NH, Lukivskaya O, Luschnig P,
Maniscalco M, Martinez JA, Müller-Krebs S, Ndrepepa G, Nicolaou G, Peck-Radosavljevic M,
Penna F, Pintó X, Reiberger T, Rodriguez-Moran M, Schmidt A, Schwenger V, Spinelli L, Starkel P,
Stehouwer CD, Stenvinkel P, Strasser P, Suzuki H, Tschoner A, van der Wal AC, Vesely DL, Wen
CJ, Wiernicki I, Zanninelli G, Zhu Y. Research update for articles published in EJCI in 2008. Eur J
Clin Invest. 2010 Sep;40(9):770-789.
80. Carrero JJ and Stenvinkel P. Inflammation in end-stage renal disease-What have we learned in 10
years? Sem Dial Sept/Oct 2010;23(5):498-509.
81. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic
implications. Kidney Blood Press Res 2010 Oct;33:383-392.
82. Gungor O, Kircelli F, Carrero JJ, Asci G, Toz H, Tatar E, Hur E, Sever MS, Aronsoy T and Ok E.
Endogenous testosterone and mortality in male hemodialysis patients; is it the result of aging? Clin J
Am Soc Nephrol. 2010 Nov;5(11):2018-23.
83. C Gracia-Iguacel, P Gallar, AR Qureshi, O Ortega, C Mon, M Ortiz, I Villarreal, C Garcia Lacalle, M
Sánchez, JC Herrero, A Vigil, B Lindholm and JJ Carrero. Vitamin D deficiency in dialysis patients:
Impact of dialysis modality and implications on outcome. J Ren Nutr. 2010 Nov;20(6):359-67.
84. CL Meuwese, N Halbesma, P Stenvinkel, FW Dekker, H Molinaei, AR Qureshi, P Barany, O
Heimburger, B Lindholm, RT Krediet, EW Boeschoten and JJ Carrero. Variations in C-reactive
protein during a single hemodialysis session do not associate with mortality. Nephrol Dial
Transplant. 2010 Nov;25(11):3717-23.
85. Nakashima A, Carrero JJ, Qureshi AR, Miyamoto T, Anderstam B, Bárány P, Heimbürger O,
Stenvinkel P and Lindholm B. Impact of circulating soluble receptor for advanced glycation end
products (sRAGE) and the pro-inflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in
hemodialysis patients. Clin J Am Soc Nephrol. December 2010;5(12):2213-19.
86. Cordeiro AC, Carrero JJ, Barany P, Qureshi AR, Heimburger O, Lindholm B, Stenvinkel P.
Glycated hemoglobin is associated to use of erythropoiesis-stimulating agents in non-diabetic
incident dialysis patients. Am J Nephrol. 2010 Dec 3;33(1):17-24.
2011
87. Muntinghe FLH, Carrero JJ, Navis G and Stenvinkel P. TNF-α levels are not increased in inflamed
patients carrying the CCR5 deletion 32. Cytokine. 2011 Jan;53(1):16-8.
88. M Verduijn, RA Prein, P Stenvinkel, JJ Carrero, A Witasp, L Nordfors, RT. Krediet, EW Boeschoten,
FW Dekker. Is fetuin-A a mortality risk factor in dialysis patients or a mere risk marker? A Mendelian
randomization approach. Nephrol Dial Transplant. 2011 Jan;26(1):239-45.
89. Carrero JJ*, de Mutsert R*, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW for the NECOSAD
Study Group. Sex differences in the impact of diabetes on mortality in end-stage renal disease.
Nephrol Dial Transplant. 2011 Jan;26(1):270-276.*Equally contributed.
90. Carrero JJ, Qureshi AR, Nakashima A, Arver S, Parini P, Lindholm B, Barany P, Heimburger O,
Stenvinkel P. Prevalence and clinical implications of testosterone deficiency in men with end-stage
renal disease. Nephrol Dial Transplant. 2011 Jan;26(1):184-90.
91. Carrero JJ. Mechanisms of altered regulation of food intake in chronic kidney disease. J Ren Nutr.
2011 Jan;21(1):7-11.
92. Chung SH, Carrero JJ, Lindholm B. Causes of poor appetite in patients undergoing peritoneal
dialysis. J Ren Nutr. 2011 Jan;21(1):12-5.
93. Akar H, Akar GC, Carrero JJ, Stenvinkel P and Lindholm B. Systemic consequences of poor oral
health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011 Jan;6(1):218-26.
94. Carrero JJ and Stenvinkel P. Predialysis chronic kidney disease in 2010: Novel targets for slowing
CKD progression. Nat Rev Nephrol. 2011 Feb;7(2):65-6.
95. Meuwese CL, Stenvinkel P, Dekker FW and Carrero JJ. Monitoring of C-reactive protein in the
dialysis patient: forewarned is forearmed. Nat Rev Nephrol. 2011 Mar;7(3):166-76.
96. Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E, Sevinc Ok E, Ozkahya M, Toz H, Cirit
M, Basci A, Ok E. Nutritional State Alters the Association between Free Triiodothyronine Levels and
Mortality in Hemodialysis Patients. Am J Nephrol. 2011 Mar 8;33(4):305-312.
97. Witasp A, Carrero JJ, Heimbürger O, Lindholm B, Hammarqvist F, Stenvinkel P and Nordfors L.
Increased expression of pro-inflammatory genes in abdominal subcutaneous fat of chronic kidney
disease patients. J Intern Med. 2011 Apr;269(4):410-9.
98. Carrero JJ, Nakashima A, Qureshi AR, Lindholm B, Barany P, Heimbürger O and Stenvinkel P.
Protein-energy wasting modifies the association of endogenous ghrelin with inflammation, leptin and
mortality in hemodialysis patients. Kidney Int. 2011 Apr;79(7):749-56.
99. Meuwese CL, Snaedal S, N Halbesma, P Stenvinkel, FW Dekker, AR Qureshi, P Barany, O
Heimburger, B Lindholm, RT Krediet, EW Boeschoten and Carrero JJ. Trimestral variations of Creactive protein, interleukin-6 and tumor necrosis factor-α are similarly associated with survival in
hemodialysis patients. Nephrol Dial Transplant. 2011 Apr;26(4):1313-8.
100. Yilmaz MI, Sonmez A, Saglam M, Ortiz A, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M,
Egido J, Altun B, Stenvinkel P, Yenicesu M, Blanco-Colio LM and Carrero JJ. Soluble TWEAK and
PTX3 in non-dialysis CKD patients; Impact on endothelial dysfunction and cardiovascular outcomes.
Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92
101. Witasp A*, Carrero JJ*, Qureshi AR, Hammarqvist F, Heimburger O, Schalling M, Lindholm B,
Nordfors L and Stenvinkel P. Expression of osteoprotegerin in human fat tissue; implications for
uremic patients. Eur J Clin Invest. 2011 May;41(5):498-506. *equally contributed.
102. Miyamoto T, Carrero JJ, Qureshi AR, Anderstam B, Heimburger O, Barany P, Lindholm B,
Stenvinkel P. Circulating follistatin levels inversely correlates with muscle strength and bone mineral
density in end-stage renal disease patients. Clin J Am Soc Nephrol. 2011 May;6(5):1001-8.
103. Luksha N, Luskha L, Carrero JJ, Hammarqvist F, Stenvinkel P, Kublickiene K. Impaired resistance
artery function in patients with end stage renal disease. Clin Sci (Lond). 2011 Jun 1;120(12):525-36.
104. Nakashima A, Carrero JJ, Qureshi AR, Hirai T, Takasugi N, Ueno T, Taniguchi Y, Lindholm B and
Yorioka N. Osteoprotegerin, arterial stiffness and mortality in long-term normoalbuminemic
Japanese hemodialysis patients. Osteoporos Int. 2011 Jun;22(6):1695-701.
105. Blanco-Colio LM, Martin-Ventura JL, Carrero JJ, Yilmaz MI, Moreno JA, Gomez-Guerrero C, Ortiz
A, Egido J. Vascular proteomics and the discovery process of clinical biomarkers: The case of
TWEAK. Proteomics Clin Appl. 2011 Jun;5(5-6):281-8.
106. Gungor O, Kircelli F, Carrero JJ, Hur E, Demirci MS, Asci G, Toz H. The effect of
immunosuppressive treatment on arterial stiffness and matrix gla protein levels in renal transplant
recipients. Clin Nephrol. 2011 Jun;75(6):491-6.
107. Meuwese CL, Carrero JJ, Stenvinkel P. Recent insights in inflammation-associated wasting in
patients with chronic kidney disease. Contrib Nephrol. 2011;171:120-6.
108. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, de Meester J, Heaf JG, Finne P, Hoitsma AJ,
Pascual J, Jarraya F, Reisaeter AV, Dekker FW, Jager KJ. Cardiovascular and noncardiovascular
mortality among men and women starting dialysis. Clin J Am Soc Nephrol. 2011 Jul;6(7):1722-30.
109. Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Kilic S, Eyileten T, Caglar K, Oguz Y,
Vural A, Çakar M, Altun B, Yenicesu M and Carrero JJ. Endogenous testosterone associates with
endothelial dysfunction and predicts cardiovascular events in men with non-dialysis chronic kidney
disease. Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25.
110. Tatar E, Asci G, Kircelli F, Carrero JJ, Gungor O, Demirci MS, Ceylan N, Ozkahya M, Toz H, Ok E.
Low Triiodothyronine Levels are Associated with Carotid Atherosclerosis and Arterial Stiffness in
Hemodialysis Patients. Clin J Am Soc Nephrol. 2011 Sep;6(9):2240-6.
111. Saldanha JF, Carrero JJ and Mafra D. The possible role of nesfatin-1 on appetite regulation in
hemodialysis patients. Med Hypotheses. 2011 Oct;77(4):654-7.
112. Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as risk factors and therapeutic targets in
chronic kidney disease. Curr Opin Nephrol Hypertens. 2011 Nov;20(6):662-8.
113.
Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A,
Çakar M, Altun B, Yenicesu M and Carrero JJ. Vascular health, systemic inflammation and
progressive reduction in kidney function; clinical determinants and impact on cardiovascular
outcomes. Nephrol Dial Transplant. 2011 Nov;26(11):3537-43
114. Miyamoto T, Qureshi AR, Heimbürger O, Bárány P, Carrero K, Sjöberg B, Lindholm B, Stenvinkel P
and Carrero JJ. Inverse relationship between the inflammatory marker pentraxin 3, fat mass and
abdominal obesity in chronic kidney disease. Clin J Am Soc Nephrol. 2011 Dec;6(12):2785-91.
2012
115. Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, Geloneze B, Mafra D.
The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there
associations with food intake, body composition and inflammation? Regul Pept. 2012 Jan 10;173(13):82-5.
116. Meuwese CL, Dekker FW, Lindholm B, Qureshi AR, Heimburger O, Barany P, Stenvinkel P and
Carrero JJ. Impact of basal and trimestral variation of triiodothyronine and thyroxine on all-cause
and cardiovascular mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2012
Jan;7(1):131-8.
117. Iglesias P, Carrero JJ and Diez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical
features, prognostic implications and therapeutic options. J Nephrol. 2012 Jan;25(1):31-42.
118. Breit SN, Carrero JJ, Tsai VWW, Yagoutifam N, Luo W, Kuffner T, Bauskin AR, Wu L, Jiang L,
Hunter M Barany P, Heimburger O, Murikami MA, Apple FS, Marquis CP, Macia L, Lin S, Sainsbury
A, Herzog H, Law M, Stenvinkel P and Brown DA. Macrophage inhibitory cytokine-1 (MIC-1/GDF15)
and mortality in end stage renal disease. Nephrol Dial Transplant. 2012 Jan;27(1):70-5.
119. Demirci MS, Gungor O, Kircelli F, Carrero JJ, Tatar E, Demirci C, Kayikcioglu M, Asci G, Toz H,
Ozkahya M, Ok E. Determinants of Arterial Stiffness Progression in Peritoneal Dialysis Patients with
Strict Volume Control. Clin Nephrol. 2012 Feb;77(2):105-13.
120. Carrero JJ, Yilmaz MI, Bárány P, Qureshi AR, Sonmez A, Heimbürger O, Ozgurtas T, Yenicesu M,
Lindholm B and Stenvinkel P. Testosterone deficiency, an additional cause of anemia and reduced
responsiveness to erythropoiesis stimulating agents in men with chronic kidney disease. Nephrol
Dial Transplant. 2012 Feb;27(2):709-15.
121. Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, Saglam M, Stylianou K,
Yaman H, Taslipinar A, Vural A, Gok M, Yenicesu M, Daphnis E and Yilmaz MI. Prolactin levels,
endothelial dysfunction and the risk of cardiovascular events or mortality in patients with chronic
kidney disease. Clin J Am Soc Nephrol. 2012 Feb;7(2):207-15.
122. Shearer GC, Carrero JJ, Heimbürger O, Barany P, Stenvinkel P. Plasma fatty acids in chronic
kidney disease: nervonic acid predicts mortality. J Ren Nutr. 2012 Mar;22(2):277-83.
123.
Nordfors L, Luttropp K, Carrero JJ, Witasp A, Stenvinkel P, Lindholm B, Schalling M. Genetic
studies in chronic kidney disease: basic concepts. J Nephrol. 2012 Mar;25(2):141-9.
124.
Kawakami-Carvalho L, Barreto-Silva MI, da Silva-Vale B, Bregman R, Brum-Martucci R, Carrero
JJ, Avesani CM. Annual variation in body fat is associated with systemic inflammation in chronic
kidney disease patients stages 3 and 4: A longitudinal study. Nephrol Dial Transplant. 2012
Apr;27(4):1423-8.
125. Molanaei H, Stenvinkel P, Qureshi AR, Carrero JJ, Heimbürger O, Lindholm B, Diczfalusy U, OdarCederlöf I and Bertilsson L. Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis
patients with persistent inflammation. Eur J Clin Pharmacol. 2012 May;68(5):571-7.
126.
Luksha L, Stenvinkel P, Hammarqvist F, Carrero JJ, Davidge ST, Kublickiene K. Mechanisms of
Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease. PLoS
One. 2012;7(4):e36056.
127.
Gungor O, Kircelli F, Carrero JJ, Hur E, Dheir H, Simsir A, Okmen F, Toz H, Hoscoskun C.
Congenital Adrenal Hyperplasia: A Rare Cause of Renal Failure and a Successful Renal
Transplantation. Clin Nephrol. 2012 Aug;78(2):145-8.
128. Huang X, Stenvinkel P, Qureshi AR, Risérus U, Cederholm T, Bárány P, Heimbürger O, Lindholm B,
Carrero JJ. Essential Polyunsaturated Fatty Acids, Inflammation and Mortality in Dialysis Patients.
Nephrol Dial Transplant. 2012 Sep;27(9):3615-20.
129. Kamimura MA, Fernandes-Canziani ME, Ribeiro-Sanches F, Modesto-Velludo C, Carrero JJ,
Bazanelli AP, Draibe SA, Cuppari L. Variations in adiponectin levels in patients with chronic kidney
disease: a prospective study of 12 months. J Bras Nefrol. 2012 Sep;34(3):259-65.
130. Jia T, Carrero JJ, Lindholm B, Stenvinkel P. The complex role of adiponectin in chronic kidney
disease. Biochimie. 2012 Oct;94(10):2150-6.
131. Carrero JJ, Stenvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic
phenotype. Nephrol Dial Transplant. 2012 Nov;27(11):4030-41.
132. Witasp A, Nordfors L, Carrero JJ, Luttropp K, Lindholm B, Schalling M, Stenvinkel P. Genetic
studies in chronic kidney disease: interpretation and clinical applicability. J Nephrol. 2012 NovDec;25(6):851-64.
2013
133.Gungor O, Kismali E, Sisman A, Dokuz E, Kircelli F, Carrero JJ, Tatar E, Asci G, Toz H. The
relationships between serum sTWEAK, FgF23 levels and carotid atherosclerosis in renal transplant
patients. Ren Fail. 2013;35(1):77-81.
134.
Jankowska M, Marszałł M, Dębska-Ślizień A, Carrero JJ, Lindholm B, Czarnowski W, Rutkowski
B, Trzonkowski P. Vitamin B6 and the immunity in the elderly kidney transplant recipients. J Ren
Nutr. 2013 Jan;23(1):57-64.
135. Gungor O, Kircelli F, Asci G, Carrero JJ, Tatar E, Demirci MS, Özbek SS, Ceylan N, Huseyin Toz
H, Ozkahya M, Ok E. Soluble TWEAK level: Is It a Marker for Cardiovascular Disease in Long-term
Hemodialysis Patients? J Nephrol. 2013 Jan;26(1):136-43.
136.
Huang X, Stenvinkel P, Qureshi AR, Cederholm T, Bárány P, Heimbürger O, Lindholm B, Risérus
U, Carrero JJ. Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1
activity indices in dialysis patients. J Intern Med. 2013 Mar;273(3):263-72.
137. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch W, Price R,
Wanner C, Wang AYM, ter Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in
chronic kidney disease: Consensus statement from the International Society of Renal Nutrition and
metabolism (ISRNM). J Ren Nutr. 2013 Mar;23(2):77-90
138. Ros S and Carrero JJ. Endocrine alterations and cardiovascular risk in CKD; Is there a link?
Nefrologia. 2013 Mar 19;33(2):181-187.
139. Barreto JGP, Barreto Silva MI, Qureshi AR, Bregman R, Faria Cervante V, Carrero JJ, Avesani CM.
Can Renal Nutrition Education Improve Adherence to a Low-Protein Diet in Patients With Stages 3
to 5 Chronic Kidney Disease? J Ren Nutr. 2013 May;23(3):164-71.
140. Witasp W, Rydén M, Carrero JJ, Qureshi AR, Nordfors L, Näslund E, Hammarqvist F, Arefin S,
Kublickiene K, Stenvinkel P. Elevated circulating levels and tissue expression of pentraxin 3 in
uremia: a reflection of endothelial dysfunction. PLoS One. 2013 May 3;8(5):e63493. PMID:
23658833.
141. Cordeiro AC, Carrero JJ, Qureshi AR, Ferreira da Cunha F, Lindholm B, de Castro I, Noronha IL.
Study on the incidence of dialysis in Sao Paulo, the largest Brazilian city. Clinics (Sao Paulo). 2013
Jun;68(6). doi:pii: S1807-59322013000600760.
142. Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D,
Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz
M, Pavlovic D, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor
P, Cannata-Andia JB. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial
Transplant. 2013 Jul;28(7):1922-35. PMID: 23166310
143. Amparo FC, Cordeiro AC, Carrero JJ, Cuppari L, Lindholm B, Amodeo C, Kamimura MA.
Malnutrition-inflammation score is associated with handgrip strength in nondialysis-dependent
chronic kidney disease patients. J Ren Nutr. 2013 Jul;23(4):283-7.
144. Gracia-Iguacel C, González-Parra E, Pérez Gómez MV, Mahillo I, Egido J, Ortiz A, Carrero JJ.
Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis
patients in a centre in Spain. Nefrologia. 2013 Jul 19;33(4):495-505.
145. Speeckaert MM, Speeckaert R, Carrero JJ, Vanholder R, Delanghe JR. Biology of human pentraxin
3 (PTX3) in acute and chronic kidney disease. J Clin Immunol. 2013 Jul;33(5):881-90.
146. Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu
M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ. Neutrophil to lymphocyte ratio
independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp
Nephrol. 2013 Aug;17(4):532-40.
147. Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M,
Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ. Serum gamma-glutamyltransferase levels
are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol. 2013
Aug;45(4):1071-8.
148.
Kamimura MA, Carrero JJ, Canziani MEF, Watanabe R, Lemos MM and Cuppari L. Visceral
obesity assessed by computed tomography predicts cardiovascular events in nondialyzed chronic
kidney disease patients. Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):891-7.
149.
Cigarran S, Pousa M, Castro MJ, Gonzalez B, Martinez A, Barril G, Aguilera A, Coronel F,
Stenvinkel P and Carrero JJ. Endogenous testosterone, muscle strength and fat-free mass in men
with chronic kidney disease. J Ren Nutr. 2013 Sep;23(5):e89-95.
150. Huang X, Jiménez-Moleón JJ, Lindholm B, Cederholm T, Ärnlöv J, Risérus U, Sjögren P, Carrero
JJ. Mediterranean diet, kidney function, and risk of mortality in men with chronic kidney disease.
Clin J Am Soc Nephrol. 2013 Sep;8(9):1548-1555.
151. Ros S, Remón C, Qureshi AR, Quiros P, Lindholm B and Carrero JJ. Increased risk of fatal
infections in women starting peritoneal dialysis. Perit Dial Int. 2013 Sep;33(5):487-94.
152. Meuwese CL, Dekkers OM, Stenvinkel P, Dekker FW, Carrero JJ. Non-thyroidal illness and the
cardio-renal syndrome. Nat Rev Nephrol. 2013 Oct;9(10):599-609.
153. Cabezas-Rodriguez I*, Carrero JJ*, Zoccali C, Qureshi AR, Ketteler M, Floege J, London G,
Locatelli F, Gorriz JL, Rutkowski B, Memmos D, Ferreira A, Covic A, Teplan V, Bos WJ, Kramar R,
Pavlovic D, Goldsmith D, Nagy J, Benedik M, Verbeelen D, Tielemans C, Wüthrich RP, Martin PY,
Fernandez-Martin JL, Cannata-Andia JB. Influence of Body Mass Index on the Association of
Weight Changes with Mortality in Hemodialysis Patients. Clin J Am Soc Nephrol. 2013
Oct;8(10):1725-1733. *Equally contributed.
154. Cordeiro AC, Qureshi AR, Lindholm B, Amparo FC, Paladino-Filho AT, Perini M, Lourenco FS,
Pinto IMF, Amodeo C, Carrero JJ. Visceral fat and coronary artery calcification in patients with
chronic kidney disease. Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv152-iv159.
155. Gracia-Iguacel C, Qureshi AR, Avesani CM, Lindholm B, Heimburger O, Huang X, Barany P, Ortiz
A, Stenvinkel P, Carrero JJ. Subclinical and overt obesity in dialysis patients; More than meets the
eye. Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv175-iv181.
156. Cannata-Andia JB, Fernández-Martín JL, Locatelli F, London G, Gorriz JL, Floege J, Ketteler M,
Ferreira A, Covic A, Rutkowski B, Memmos D, Bos WJ, Teplan VT, Nagy J, Tielemans C, Verbeelen
D, Goldsmith D, Kramar R, Martin PY, Wüthrich RD, Pavlovic D, Benedik M, Martínez-Camblor P,
Naves-Díaz M, Carrero JJ, Zoccali C. Use of phosphate-binding agents is associated with a lower
risk of mortality. Kidney Int. 2013 Nov;84(5):998-1008.
157. Meuwese CL and Carrero JJ. Chronic kidney disease and hypothalamic-pituitary axis dysfunction:
the chicken or the egg? Arch Med Res. 2013 Nov;44(8):591-600.
158. Frostegård AG, Hua X, Su J, Carrero JJ, Heimbürger O, Bárány P, Stenvinkel P, Frostegård J. IgM
antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in
hemodialysis patients, negatively associated with mortality. Clin Exp Immunol. 2013
Dec;174(3):441-8.
159. Meuwese CL, Carrero JJ, Cabezas-Rodríguez I, Heimburger O, Barany P, Qureshi AR, Ripsweden
J, Lindholm B, Dekker FW, Stenvinkel P. Non-thyroidal illness - a risk factor for coronary calcification
and arterial stiffness in patients undergoing peritoneal dialysis. J Intern Med. 2013 Dec;274(6):58493.
160. Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz O,
Sari S, Yildirim AO, Vural A, Carrero JJ*, Blanco-Colio LM*. Soluble TWEAK plasma levels
increase after renal transplantation and associate with the improvement of endothelial function.
*equally contributed. Eur J Clin Invest. 2013 Dec;43(12):1250-7.
161. Huang X, Stenvinkel P, Lindholm B, Carrero JJ. Dietary fat modification in patients with chronic
kidney disease: n-3 fatty acids and beyond. J Nephrol. 2013 Dec 5;26(6):960-74.
2014
162. Huang X, Sjögren P, Arnlöv J, Cederholm T, Lind L, Stenvinkel P, Lindholm B, Risérus U, Carrero
JJ. Serum fatty acid patterns, insulin sensitivity and the metabolic syndrome in individuals with
chronic kidney disease. J Intern Med. 2014 Jan;275(1):71-83.
163. Huang X, Sjögren P, Cederholm T Arnlöv J, Lindholm B, Risérus U, Carrero JJ. Serum and adipose
tissue fatty acid composition as biomarkers of habitual dietary fat intake in elderly men with chronic
kidney disease. Nephrol Dial Transplant. 2014 Jan;29(1): 128-136
164. Carrero JJ and Cozzolino M. Nutritional therapy, phosphate control, and renal protection. Nephron
Clin Pract 2014;126:1-7.
165. Bobrowski L, Łukaszuk L, Lindholm B, Stenvinkel P, Heimburger O, Axelsson J, Bárány P, Carrero
JJ, Qureshi AR, Luttropp K, Debowska M, Nordfors L, Schalling M, and Waniewski J. Selection of
genetic and phenotypic features associated with inflammatory status of patients with chronic kidney
disease using relaxed linear separability method. PLoS One. 2014 Jan 28;9(1):e86630. doi:
10.1371/journal.pone.0086630. eCollection 2014.
166. Bello AK, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D,
Cembrowski G, Strippoli G, Carrero JJ, Tonelli M. Serum testosterone levels and clinical outcomes
in male hemodialysis patients. Am J Kidney Dis. 2014 Feb;63(2):268-75.
167. Cordeiro AC, Lindholm B, Sousa MG, Cezar-Picotti J, Nunes GJ, Santana MRO, Grimaldi W,
Amparo FC, Amodeo C, Carrero JJ. Reliability of Electrocardiographic Surrogates of Left
Ventricular Mass in Patients with Chronic Kidney Disease. J Hypertens. 2014 Feb;32(2):439-45.
168. Huang X and Carrero JJ. Better prevention than cure: optimal patient preparation for renal
replacement therapy. Kidney Int. 2014 Mar;85(3):507-10.
169. Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson S,
Jernberg T. Warfarin treatment, kidney dysfunction and outcomes in acute myocardial infarction
patients with atrial fibrillation. JAMA. March 2014; 311(9):913-915.
170. Chmielewski M, Cohen G, Wiecek A, Carrero JJ. The peptidic middle molecules: is molecular
weight doing the trick? Seminars in Nephrology. 2014 March;34(2): 118-134.
171. Xu H, Huang X, Arnlöv J, Cederholm T, Stenvinkel P, Lindholm B, Risérus U, Carrero JJ. Clinical
determinants and mortality predictability of insulin sensitivity in men with chronic kidney disease
stages 3-4. Clin J Am Soc Nephrol. 2014 Apr;9(4):690-697.
172. Snaedal S, Qureshi AR, Carrero JJ, Heimbürger O, Stenvinkel P, Bárány P. Determinants of NtproBNP variation in hemodialysis patients and prediction of survival. Blood Purif. 2014 Apr
8;37(2):138-145.
173. Cordeiro AC , Moraes AAI, Cerutti V, França F, Quiroga B, Amodeo C, Picotti JC, Dutra LV ,
Rodrigues GD, Amparo FC, Lindholm BL, and Carrero JJ. Electrocardiographic strain pattern in
chronic kidney disease patients: clinical determinants and outcome predictability. J Am Soc
Hypertens. 2014 May;8(5):312-20.
174. Witasp A, Carrero JJ, Michaelsson K, Ahlström H, Johansson L, Andersson L, Risérus U, Larsson
A, Helmersson-Karlqvist J, Lind L, Stenvinkel P, Arnlöv J. Inflammatory biomarker pentraxin 3
(PTX3) in relation to obesity, body fat depots and weight loss. Obesity (Silver Spring). 2014
May;22(5):1373-9.
175. Luis D, Huang X, Sjögren P, Risérus U, Ärnlöv J, Lindholm B, Cederholm T, and Carrero JJ. Renal
function associates with energy intake in elderly community-dwelling men. Br J Nutr. 2014
Jun;111(12):2184-9.
176. Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V, Allolio B, Wanner C,
Fassnacht M. Thyroid Function, Cardiovascular Events, and Mortality in Diabetic Hemodialysis
Patients. Am J Kidney Dis. 2014 Jun;63(6):988-96.
177. Shiraki N, Nakashima A, Doi S, Carrero JJ, Sugiya N, Ueno T, Stenvinkel P, Yorioka N, Kohno N,
and Masaki T. Low serum testosterone is associated with atherosclerosis in postmenopausal
women undergoing hemodialysis. Clin Exp Nephrol. 2014 Jun;18(3):499-506.
178. Izquierdo MC, Martin-Cleary C, Fernandez-Fernandez B, Elewa U, Sanchez-Niño MD, Carrero JJ,
Ortiz A. CXCL16 in kidney and cardiovascular injury. Cytokine Growth Factor Rev. 2014
Jun;25(3):317-25.
179. Carrero JJ, Szummer K, Jernberg T. Influence of chronic kidney disease on warfarin therapy for
atrial fibrillation-reply. JAMA. 2014 Jun 25;311(24):2542-3.
180. Gracia-Iguacel C, González-Parra E, Barril-Cuadrado G, Sánchez R, Egido J, Ortiz-Arduán A,
Carrero JJ. Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and
clinical implications. Nefrologia. 2014 Jul 14;34(4):507-519.
181. Xu H, Jia T, Huang X, Risérus U, Cederholm T, Ärnlöv J, Sjogren P, Lindholm B, Carrero JJ.
Dietary acid load, insulin sensitivity and risk of type 2 diabetes in community-dwelling older men.
Diabetologia. 2014 Aug;57(8):1561-8.
182. Xu H, Huang X, Risérus U, Cederholm T, Lindholm B, Ärnlöv J, Carrero JJ. Urinary albumin
excretion and ambulatory blood pressure progression in the community: effect modification by
kidney function. Nephrol Dial Transplant. 2014 Aug;29(8):1538-45.
183. Jia T, Huang X, Xu H, Arnlöv J, Lindholm B, Cederlholm T, Stenvinkel P, Risérus U, Carrero JJ.
Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals
with and without impaired renal function. Kidney Int. 2014 Aug;86(2):383-91.
184. Carrero JJ. Testosterone deficiency at the crossroad of cardiometabolic complications of chronic
kidney disease. Am J Kidney Dis. 2014 Sep;64(3):322-5.
185. Xu H, Cabezas-Rodriguez I, Qureshi AR, Heimburger O, Barany P, Anderstam B, Bragfors-Helin
AC, Carrero JJ, Stenvinkel P and Lindholm B. Increased levels of modified advanced oxidation
protein products (AOPP) are associated with central and peripheral blood pressure in peritoneal
dialysis patients. Perit Dial Int. 2014 Mar 1. [Epub ahead of print]
186. Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ,
Stenvinkel P, Covic A, Kanbay M. The relationship between interleukin-10 levels and cardiovascular
events in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2014 May 1. [Epub ahead of
print].
187. Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T, Saglam M, Unal HU, Gok M, Polat A,
Cetinkaya H, Eyileten T, Sari S, Yildirim AO, Oguz Y, Vural A, Carrero JJ. Endothelial function in
patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular
events. Rheumatology (Oxford). 2014 Jun 6. pii: keu231. [Epub ahead of print].
188. Carrero JJ, Chen J, Kovesdy CP and Kalantar-Zadeh K. Critical appraisal of biomarkers of dietary
intake and nutritional status in patients undergoing dialysis. Semin Dial. 2014 Jul 10. doi:
10.1111/sdi.12283.
189. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimbürger O, Cederholm T,
Stenvinkel P and Carrero JJ. Comparative associations of muscle mass and muscle strength with
mortality in dialysis patients. Clin J Am Soc Nephrol. 2014 Jul 29. pii: CJN.10261013. [Epub ahead
of print].
190. Carrero JJ, Avesani CM. Pros and cons of body mass index as a nutritional and risk assessment
tool in dialysis patients. Semin Dial. 2014 Aug 4. doi: 10.1111/sdi.12287. [Epub ahead of print].
2. Book Chapters.
1.
Lluch C, Carrero JJ, Tejera N and Ocaña A, “Ecofisiología Vegetal”, in "Interacción PlantaMicroorganismos del Suelo: Simbiosis Fijadoras de Nitrógeno" Paraninfo ed, pags. 331-360, 2002.
ISBN 84-9732-267-3.
2.
Carrero JJ, Campos R, Tejera N, Ocaña A and Lluch C, “Efecto del estrés salino en la fijación de
nitrógeno en el metabolismo oxidativo en nódulos de Phaseolus vulgaris”, in “Avances en el
Metabolismo del Nitrógeno: De la Biología Molecular a la Agronomía” Lankopi S.A ed., pags 361368, 2002. ISBN 84-95075-88-1.
3.
Carrero JJ, Heimburger O, Chan M, Axelsson J, Stenvinkel P, Lindholm B. Protein-energy
malnutrition/wasting during peritoneal dialysis. In Nolph and Gokal´s Textbook of peritoneal dialysis,
3rd edition.Khanna and Krediet eds. Springer 2009. ISBN 978-0-387-78939-2.
4.
Carrero JJ, Avesani C, Yilmaz MI, Lindholm B, Stenvinkel P. Low-grade persistent inflammation
and immune dysfunction in uremia. In Principles and Practice of Dialysis, 4th Edition, William
Henrich, Editor. Wolters Kluwer/Lippincott Williams & Wilkins 2009. ISBN 978-0-7817-8163-3.
5.
Carrero JJ, Stenvinkel P. Cardiovascular risk factors in chronic kidney disease: traditional, nontraditional, and uremia-related threats. In Cardiorenal Syndrome: Mechanisms, risk and treatment.
Editors Berbari & Mancia. Springer-Verlag Italia, 2010. ISBN 978-88-470-1462-6.
6.
Carrero JJ, Gonzalez ME. La inflamación en diálisis. In Nefrología al día, online edition. Editors
Lorenzo V, López-Gomez JM, Martín de Francisco AL and Hernández D. Spanish Society of
Nephrology, 2011. ISBN: 978-84-96727-97-7
7.
Carrero JJ, Stenvinkel P, Lindholm B. Endocrine aspects of chronic kidney disease. In Brenner &
Rector’s The Kidney, 9th Edition. ISBN-10: 1416061932. Saunders; 9th Revised edition (29 Dec
2011). Eds. Taal, Chertow, Marsden, Skorecki, Yu & Brenner.
8.
Carrero JJ. Chronic Kidney Disease. In Handbook of clinical gender medicine. ISBN 978-3-80559929-0. 2012. Eds. Schenck-Gustafsson. DeCola, Pfaff, Pisetsky. S. Karger AG.
9.
Carrero JJ, Stenvinkel P. Anorexia and Appetite Stimulants in Chronic Kidney Disease. In
Nutritional Management of Renal Disease, 3 rd Edition. ISBN-10: 9780123919342 Editors Massry,
Kalantar-Zadeh and Kopple. Elsevier Inc (28 Jan 2013).
10. Carrero JJ, Stenvinkel P. Inflammation as a cause of protein-energy wasting in chronic kidney
disease. In Nutritional Management of Renal Disease, 3 rd Edition. ISBN-10: 9780123919342 Editors
Massry, Kalantar-Zadeh and Kopple. Elsevier Inc (28 Jan 2013).
11. Sánchez R, Carrero JJ, Fernández-Lucas M, Barril G. Nutrición en la enfermedad renal crónica.
2013 © Editrain. ISBN: 978-84-15498-45-2
12. Carrero JJ, Molina M. Desgaste proteico energético en la insuficiencia renal crónica: prevalencia e
implicaciones clínicas. In “Nutrición Clínica en Insuficiencia Renal Crónica y Transplante Renal.
Visión Internacional). Ed Alejandro Treviño-Becerra. 3rd Edition. Editorial Prado (Mexico), 2014.
ISBN 978-607-7566-64-9.
13. Carrero JJ, Stenvinkel P. Inflammation in Chronic Kidney Disease. In Oxford Textbook of Clinical
Nephrology (OTCN), 4th Edition. Editors Turner, Goldsmith, Winearls, Lameire, Himmelfarb, Wanner
and Remuzzi (In Press).
14. Avesani CM, Carrero JJ, Lindholm B, Stenvinkel P. Protein-energy wasting in chronic kidney
disease. In Oxford Textbook of Clinical Nephrology (OTCN), 4th Edition. Editors Turner, Goldsmith,
Winearls, Lameire, Himmelfarb, Wanner and Remuzzi (In Press).
15. Carrero JJ, Hong X, Lindholm B. Diet and the progression of kidney disease. In Oxford Textbook of
Clinical Nephrology (OTCN), 4th Edition. Editors Turner, Goldsmith, Winearls, Lameire, Himmelfarb,
Wanner and Remuzzi (In Press).
16. Carrero JJ, Stenvinkel P, Lindholm B. Endocrine aspects of chronic kidney disease. In Brenner &
Rector’s The Kidney, 10th Edition. Saunders; Eds. Taal, Chertow, Marsden, Skorecki, Yu & Brenner.
(In Press).
17. Sanchez KV and Carrero JJ. Inflammation-malnutrition in end-stage renal disease. What have we
learned in 15 years? Proceedings of the 45th course on advances in Nephrology, Dialysis and
Transplantation, 2014 (In Press).